Efficacy and safety of pembrolizumab monotherapy in patients with advanced thyroid cancer in the phase 2 KEYNOTE‐158 study

Oh, Do‐Youn; Algazi, Alain; Capdevila, Jaume; Longo, Federico; Miller, Wilson; Tan Chun Bing, Jerry; Eduardo Bonilla, Carlos; Cheol Chung, Hyun; K. Guren, Tormod; Lin, Chia‐Chi; Motola‐Kuba, Daniel; Shah, Manisha; Hadoux, Julien; Yao, Lili; Jin, Fan; Norwood, Kevin; Lebellec, Loïc

doi:10.1002/cncr.34657

Public

Efficacy and safety of pembrolizumab monotherapy in patients with advanced thyroid cancer in the phase 2 KEYNOTE‐158 study

Shared by NobleBlocks on Feb 7, 2023 • 12:00 AM UTC

Authors:

Do‐Youn Oh

Alain Algazi

Jaume Capdevila

Abstract

Abstract Background The authors report results from the thyroid carcinoma cohort of the multicohort phase 2 KEYNOTE‐158 study (NCT02628067), which evaluated pembrolizumab monotherapy in patients with previously treated cancers. Methods Eligible patients had histologically and/or cytologically confir...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!